Testing Disulfiram for Rheumatoid Arthritis Treatment
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This study tests whether disulfiram, a medication traditionally used to help people avoid alcohol, might help reduce inflammation and symptoms in people with active rheumatoid arthritis. Researchers will monitor how well it works and whether it's safe when combined with your current arthritis medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 75 years old
- Diagnosed with rheumatoid arthritis using standard criteria
- Currently experiencing active arthritis symptoms (high disease activity)
- On stable arthritis medications for at least 3 months before starting the study
- Willing to not drink alcohol for the entire study duration
- Healthy liver, heart, and kidneys (confirmed by blood tests)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an anti-inflammatory diet can help people with rheumatoid arthritis by lowering inflammation and disease activity. You may join if your symptoms are currently mild to moderate and you haven’t recently changed medications or your treatment plan.
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
This trial tests an experimental drug for people with rheumatoid arthritis who have not had success with other treatments. It aims to see if the drug can help reduce joint pain and swelling.
This study tests whether combining resistance exercise (like strength training) with an anti-inflammatory diet can help reduce pain, improve daily function, and boost quality of life for people with rheumatoid arthritis.
This study tests a new investigational drug called SR-878 for people with rheumatoid arthritis. It aims to see if the drug is safe and tolerable. You may join if you are between 18 and 60, have RA for at least 3 months, and take a stable dose of methotrexate.
This trial tests a new medication (BMS-986454) for people with rheumatoid arthritis who haven't responded well enough to methotrexate. It aims to see if the drug is safe and how it works in the body.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.